UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006462
Receipt number R000007524
Scientific Title A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection
Date of disclosure of the study information 2011/10/05
Last modified on 2014/10/03 10:28:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

Acronym

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

Scientific Title

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

Scientific Title:Acronym

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

Region

Japan


Condition

Condition

Benign or malignant pulmonary lesions

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy and safety of Endo GIA Tri-Staple, a surgical stapler that was newly introduced to clinical practice.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Incidence of prolomged air leaks (pulmonary fistula) that continue for more than five postoperative days

Key secondary outcomes

Incidence of air leaks occurring in the cut end during operation, incidence and degree of damage to the pleura, staple formation, haemostatic effect on the staple line, presence or absence of additional suture, whether or not sealing technique is applied and applied procedure, incidence of perioperative and postoperative adverse events, duration of placement of drain, duration of hospitalization (days)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Endo GIA Tri-Staple

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Pulmonary resection (excluding pneumonectomy) using surgical stapler is scheduled (regardless of cancer or non-cancer).
2) 20 years old or older (no upper limit)
3) No past history of ipsilateral thoracotomy
4) No past history of radiation therapy in the chest
5) No past history of chemotherapy with anticancer agent/s
6) Eastern Cooperative Oncology Group Scale of Performance Status (ECOG PS) of either 0 or 1
7) Written informed consent is obtained from the patient him/herself.

Key exclusion criteria

1) Patients who are scheduled for a lobectomy and who are found to have a complete interlobar fissure when the chest is opened (surgical stapler is not needed for interlobar separation)
2) Patients in which factors predicting non-curable resection for lung cancer, such as pleural dissemination and malignant pleural effusion, are observed when the chest is opened
3) Patients who are complicated by active infection that requires treatment other than external medicine
4) Patients who continue on systemic steroid preparation (oral or intravenous) until the day of the operation
5) Patients who are complicated by poorly controlled diabetes mellitus (HbA1C>8.0)
6) Functions of the main organs are not maintained (Common terminology criteria for adverse events (CTCAE) ver. 4.0 Grade>=2).
7) Patients with malignant pleural effusion or cardiac effusion
8) Patients who are complicated by psychiatric disorders or psychiatric symptoms and who are judged to have difficulties in participating in the study
9) Other patients who are considered by the investigator or sub-investigator as not suitable for participation in this study

Target sample size

59


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Haruhiko Nakayama

Organization

Kanagawa Cancer Center

Division name

Department of Thoracic Surgery

Zip code


Address

1-2 Nakao 1-chome, Asahi-ku, Yokohama City, Kanagawa, 241-8515

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Masahiro Tsuboi

Organization

Kanagawa Cancer Center

Division name

Department of Thoracic Surgery

Zip code


Address

1-2 Nakao 1-chome, Asahi-ku, Yokohama City, Kanagawa, 241-8515

TEL

045-391-5761

Homepage URL


Email



Sponsor or person

Institute

Kanagawa Cancer Center
Department of Thoracic Surgery

Institute

Department

Personal name



Funding Source

Organization

Covidien Japan Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 05 Month 09 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 10 Month 03 Day

Last modified on

2014 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007524


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name